Analyst Raises Price Target for Uber Technologies (NYSE: UBER) Amid Strong Growth Prospects
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameAbattis Bioceuticals Corp.
-
Registration countryCanada
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









